Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia

Author
CHERUBIN, Pierre
Ucok, Alp
JANIK, Adam
LAHAYE, Marjolein
HARGARTER, Ludger
Schreiner, Andreas
Aadamsoo, Kaire
Altamura, A. Carlo
Franco, Manuel
Gorwood, Philip
Neznanov, Nikolaj G.
SCHRONEN, Juan
ZINK, Mathias
Metadata
Show full item record
Abstract
Objective: Relapse and acute exacerbation are common in schizophrenia and may impact treatment response and outcome. Evidence is conflicting in respect to superiority of long-acting injectable antipsychotic therapies versus oral antipsychotics in relapse prevention. This randomized controlled study assessed the efficacy of paliperidone palmitate versus oral antipsychotics for relapse prevention.
URI
http://hdl.handle.net/20.500.12627/7951
https://doi.org/10.1016/j.schres.2015.08.015
Collections